Viacoram® - focus on blood pressure target

Viacoram® - focus on blood pressure target. An open single-arm non-interventional observational study in hypertensive outpatients treated with Viacoram® in Germany.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN26323538

Enrollment

3000

Registered

2015-10-28

Start date

2015-09-21

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension Circulatory System Essential (primary) hypertension

Interventions

This is strictly a non-interventional observational study. Only interventions in line with and not exceeding the standard medical routine are allowed. All patients involved in the study will be treate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with essential hypertension with currently not controlled blood pressure eligible for the treatment with Viacoram® for whom the treatment decision was done prior to study inclusion.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Office blood pressure measured within the daily medical routine at inclusion, after approx. 1 month, 2 months and at study final examination after approx. 3 months.	—

Secondary

Measure	Time frame
1. Ambulatory BP monitoring only in measured as part of the medical routine at inclusion, after approx. 1 month, 2 months and at study final examination after approx. 3 months 2. Central BP parameters only in measured as part of the medical routine at inclusion, after approx. 1 month, 2 months and at study final examination after approx. 3 months 3. Assessment of therapy adherence measured by means of the Hill-Bone-Scale	—

Measure

Time frame

1. Ambulatory BP monitoring only in measured as part of the medical routine at inclusion, after approx. 1 month, 2 months and at study final examination after approx. 3 months 2. Central BP parameters only in measured as part of the medical routine at inclusion, after approx. 1 month, 2 months and at study final examination after approx. 3 months 3. Assessment of therapy adherence measured by means of the Hill-Bone-Scale

—

Countries

Germany

Contacts

Public ContactPeter Martinka

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026